New Cancer Treatment Compounds from Garlic

The technology promises to be a new treatment for breast or oesophageal cancer. This drug candidate shows great promise in vitro at inducing cytotoxicity in cancer cell lines with similar activities to very potent clinical chemotherapeutics currently on the market. In addition, there are no similar chemotherapies based on this compound class, meaning it is a new chemotype which has a unique mechanism of action. In addition, it may hold promise when used as an alternative or in combination when other known chemotherapies in order to prolong the life of the chemotherapy and to delay the onset of chemoresistance